7. Cancer IV Flashcards

(39 cards)

1
Q

• Tumor starts as one clone, or a group of cells that have a specific mutation that allows the cell to transform to a malignant phenotype
○ Cancer is ____
• What causes transformation?
○ ____ mutation that occurs in division in absence of external stimulus
○ Causative agents
§ Chemical, radiation, viral, and microbial types

A

monoclonal

spontaneous

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Carcinogenic Agents

  • ____ Carcinogens
  • Radiation
  • ____ and Microbial
  • May act alone or in concert
A

chemical

viral

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Chemical Carcinogens
Direct-Acting
 Do not require ____
 Used as ____

Indirect-Acting
 Metabolized by ____ dependent monooxygenase
 ____ vary among individuals – personalized medicine target

• Direct-acting
	○ Alkylating agents - used to treat cancer because it causes \_\_\_\_ damage and causes cell to die
	○ Used to treat cancer because they divide faster, so they're more sensitive to damage via AA
	○ They're carcinogenic, but not strongly carcinogenic; the risk must be taken in order to remove the current cancer
	○ \_\_\_\_, chlornambucil, \_\_\_\_ are examples of anticancer drugs

• Indirect-acting
	○ Once \_\_\_\_ it becomes carcinogenic
	○ Enzymes can differ in \_\_\_\_ form one person to another - variability - due to certain AA having slight differences, no change in structure only in activity
		§ If one person has slightly higher activity, will convert the chemical faster/higher amount > higher chance to develop \_\_\_\_
		§ Personalized medicine - your risk is higher if exposed to this potential carcinogen
A

metabolism
chemotherapeutics

p450
alleles

irreversible
cyclophosphamide
nitrosurea

metabolized
activity
cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Indirect-acting Carcinogens

Polycyclic hydrocarbons
 ____
 Cigarette smoke
 ____ in meat

Aromatic Amines
 ____ dye industry
– ____ – bladder cancer

• Polycyclic hydrocarbons
	○ Benzopyrenes come from fossil fuels and cigarette smoke
• Aromatic amines
	○ Dyes that have been used in last 200 years to produce the color blue, yellow
		§ Workers that were exposed - higher rates of cancers
• These both require \_\_\_\_ activation
A

fossil fuels
broiled fat

analine
b-naphtylamine

metabolism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Natural Indirect Carcinogens and others

 ____ – produced by Aspergillis strains found on poorly stored nuts

* Consumption of these nuts has led to increase incidence \_\_\_\_ cancer
* \_\_\_\_ plants can be a source of carcinogens
* Betel nuts - chewed that can lead to oral cancer
* Pesticides/home compounds can also lead to cancer
A

aflatoxin B1
hepatocellular
natural

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Mechanisms of Chemical Carcinogens

Initiators:
 DNA \_\_\_\_ agents
 Some target specific gene more often
 \_\_\_\_
 TP53 – “\_\_\_\_”
Promoters
 Induce cell \_\_\_\_
 Non \_\_\_\_
 Induce cell proliferation
 make mutations in initial clone cell \_\_\_\_
 Accumulation of additional mutations
 e.g \_\_\_\_, hormones, phenols
A

damaging
Ras
signature mutation

cell growth
tumorigenic
permanent
phorbol esters

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Radiation Carcinogenesis

Induces DNA damage 
 UV rays
 \_\_\_\_ dimers 
 Nucleotide Excision Repair
 Skin cancers
-- Squamous and Basal cell carcinoma– \_\_\_\_ sun exposure
-- Melanoma - Intense \_\_\_\_ sun exposure 
-- \_\_\_\_ Carcinogenesis
 Radionuclides, Ionizing radiation -
\_\_\_\_ DNA breaks 
\_\_\_\_ repair 
Non-homologous End joining
Used in therapy with \_\_\_\_ consequences to adjacent tissues
A

pyrimidine
accumulated
intermittent
field

double stranded
recombination
secondary

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

• Damage type differs between UV exposure and ionizing radiation
• UV exposure
○ Dimerized of pyrimidines that are ____ bound leading to an error
§ The nt will have to be excised via ____
□ If you have deficiencies - ____ - very sensitive to UV damage
○ Too much damage will overcome the capability of NER > carcinogenic process occurring
○ The more sunlight you’re exposed to, the more likely you’ll develop squamous/basal cell carcinoma
§ ____ people are more susceptible to sun cancer formation
○ The whole area is exposed to UV light, there will be mutations, but won’t be the same in all ____ > but the whole field has a higher chance of cancer development
§ Field carcinogenesis, also occurs in the oral cavity

• Ionizing radiation
	○ Can lead to \_\_\_\_, translocations and sometimes mutations (but less likely), leading to \_\_\_\_ to repair the break; or \_\_\_\_ (resulting in genomic instability)
	○ Thyroid cancer - a secondary tumor down the line can occur from treatment; can be in the same or adjacent tissue
A

covalently
NER
XP

fair-skinned
cells
deletions
recombination
non-homologous end joining
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Host Defense against Tumors: Tumor Immunity

 Tumors must evade ____ surveillance
 Immune ____ increases risk for tumors
 Challenge is finding tumor specific antigens

Targeting cytotoxic T-cells against Tumor specific antigens
 \_\_\_\_ and mutant tumor suppressors
 Viral antigens
 \_\_\_\_ proteins
 Other mutated cellular proteins
• If person is immunocompromised, risk of cancer is increased
	○ In \_\_\_\_ immunocompromised and \_\_\_\_ patients it is evident
	○ Immune suppression by \_\_\_\_ can also increase the risk for tumors
• Before we can train immune system to attack tumor, we need to train it to recognize tumor-specific antigens
	○ Categorized into these fours
• Most important cell-type in tumor immunity is \_\_\_\_
	○ Recognize antigens
A

immune
suppression
oncoproteins
overexpressed

congenital
transplant
drugs
CTL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Oncogenes and mutant tumor suppressors

 Mutations in protooncogenes and tumorsuppressors induce new antigens
 E.g. ____, ras, ____, and CDK4, her2/neu

 So far only ____ antibodies appear to be protective for breast cancer

• Normally endogenously expressed due to mutations, and now they are new:
	○ B-cat, ras, p53 and CDK4
• Her2/neu - GFR
	○ Not mutated, but it's \_\_\_\_ in breast cancers
	○ Already on the \_\_\_\_, and targeted therapy can shut down the signaling mechanism and kill the cells
A

b-catenin
p53
her2/neu

overexpressed
surface

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Other Mutated Proteins

 Genomic instability leads to mutation in numerous genes
 Altered protein products would be ____ to the cancer cells

 Diverse and varied targets, perhaps unique to each tumor
 Chemical and radiation induced changes may have “____” like p53 for aflatoxin B1

• Any gene can be mutated, so it is extremely diverse, and it would trigger an immune response
• Can be helpful: when carcinogens can induce \_\_\_\_ mutations
	○ P53, aflatoxin B1 produces a toxin that induces a mutation which can link the cancer to aflotoxin exposure
A

unique
signature mutation
specific

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Overexpression of normal proteins

 Select cell expression at low level perhaps does not induce “____”
 Now target for tumors that have deregulated these gene products

 \_\_\_\_ in melanocytes
 Cancer-Testis antigens
-- Sperm do not express \_\_\_\_
-- e.g. Melanoma Antigen 1 (MAGE1)
=== 37% of melanomas
=== Also found in subset of lung, liver, stomach an esophageal tumors
• Sometimes genes that are usually repressed, but they become activated and express their products
	○ Initially at such a low level/not expressed, so immune system was not trained so there's no \_\_\_\_
	○ An immune response is induced
		§ Tyrosinase
			□ Expressed, but in very \_\_\_\_ levels
			□ Immune system doesn't normally detect it - untrained to recognize as self
			□ Malignant melanoma - \_\_\_\_ levels increase - triggers an immune response
		§ Cancer-testis antigens
			□ Only expressed in sperm, and because it doesn't express MHCI (need it to present antigen to cell surface); the immune system has not been exposed to antigens
			□ In cancers they're not repressed, and expressed by other cells (which have MHCI) and the immune system recognizes it as foreign and targets it
			□ \_\_\_\_ and RAGE are examples
A

self-tolerance
tyrosinase
MHC class I
self-tolerance

low
tyrosinase
MAGE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Viral antigens

 ____ and EBV produce viral product kept in check by immune surveillance
 Effectiveness of Vaccine against HPV supports the role of the ____

• Immune system can be used to protect against cancer
	○ Person has a vaccine against HPV - immune surveillance set to look for HPV antigens
	○ If a cell that is transforming to cancer due to HPV > you have trained the immune system to go and kill the transforming cell
		§ Decreases incidence of HPV induced \_\_\_\_ cancer
A

HPV
immune system
cervical

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Other Targets

 Oncofetal proteins
—  ____ protein re-expressed in tumors

 glycolipids and glycoproteins

  • –  ____ specific glycolipids/proteins would be sequestered
  • –  Seen on non-____ tumors

 Differentiation specific antigens
— ____ tissue of origin for tumor

• Oncofetal proteins
	○ Initially shut down following fetus is born, and then the repression is lifted during carcinogenesis
	○ \_\_\_\_
		§ Expressed in colon/stomach cancer
	○ \_\_\_\_
		§ Expressed in liver cancer
	○ Both antigens are detected in serum, and supports the diagnosis (not the \_\_\_\_ itself!)
• Glycolipids/glycoproteins
	○ Normally not exposed to immune system due to location
		§ \_\_\_\_ - found on apical side of ductal side of breast epithelium
			□ No exposure to immune cells, and they don't know that it's endogenous protein
			□ Upon cancer losing contact and \_\_\_\_, the apical membrane becomes exposed to the immune system
• Differentiation specific antigens (CD#)
	○ Expressed on B cells, T cells and blood cells
		§ Based on the antigen expression - can categorize the \_\_\_\_
		§ In lymphoma, can deduce the cell type using this mechanism
A

fetal
ductal
polarized

delineate

carcinoembryonic antigen (CEA)
alfofetal protein (AFP)

diagnosis
mucin-1

polarity
cell type

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Anti-tumor mechanisms

Cell mediated immunity
 Cytotoxic T-cells
— ____ cells respond to viral tumors
 Natural Killer cells
— Target tumors that downregulate ____
— Diverse receptors, including ____ induced antigens

Macrophages
 ____ produced by Cytotoxic T cells and NK cells activates Macrophages

Humoral immunity
 Anti CD20 AB treats ____

• NK cells
	○ Downregulate MHCI so the cancer cells become more susceptible to NK cells (because they're killing CTL)
	○ Cancer cells under stress express antigens that are targeted by the NK
	○ Less selective than \_\_\_\_
• Macrophages
	○ Produce \_\_\_\_, other cytokines and cause death
	○ Inflammation that is seen in tumors - while it is there to control growth, it can lead to \_\_\_\_ itself - precipitating more damage
		§ Double-edged sword
• Humoral immunity
	○ NHL - cancer cells overexpress CD20 - can use ab against the CD20 antigen leading to a burst of the tumor cell
A

CD8+
MHC class I
stress

INFg

non-hodgkin lymphoma

CTL
ROS
DNA damage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Immune Surveillance and Immune Evasion

 Immunodeficiency increases risk 200 fold
 ____ Immunodeficiency
 ____ patients
 ____-infection

 Immune competent host develop cancer
 Tumors must evade the immune system

A

congenital
transplant
HIV

17
Q

Mechanisms of Immune evasion

 ____ of immune system eliminate highly antigenic tumor cells
 Reduction/loss of ____ markers
 Antigen Masking – Thicker coat of ____ hides antigens

 Induction of immunosuppression
— Expression of ____
— Engagement of T-cell inhibitory receptor, ____
— Expression of ____ – apoptosis
 Downregulation of co-stimulatory molecules needed for strong ____ response

• Cancer cells will try to lose their MHC, so the immune system will not recognize the cancer cells
• Induction of immunosuppression
	○ Growth inhibition by TGF-b > the expression of TGF-b can lead to immunosuppression as well
	○  Can utilize CTLA4 that will dampen the immune response
	○ Tumor cells can express and secrete FasL, which will bind to Fas receptor and will induce apoptosis of the \_\_\_\_ cell
A

selective pressure
histocompatability
glycolipids

TGFb
CTLA4
FasL
T cell

immune

18
Q

Clinical Aspects of Cancer
 Effects of tumor on Host
 ____ of Cancer
 ____ Diagnosis

 How do we recognize cancer?

A

grading and staging

laboratory

19
Q

Effects of Tumor on Host - Location

 Mass effects

  • - ____ or malignant tumors
  • - Block flow in ____, duct, bowel etc
  • – e.g ____ artery, liver, intestine
  • - Compress/damage normal tissue
  • – e.g ____ adenoma compression of gland
 Produce hormones
-- e.g Pancreatic b-cell tumors – \_\_\_\_
 Ulcerate surface 
-- \_\_\_\_
-- Secondary infection 
 Intussusception
-- Tumor protruding into gut lumen caught in \_\_\_\_
A

benign
vessel
renal
pituitary

hyperinsulinemia
bleeding
peristaltic pull

20
Q

• Mass effects
○ Based on ____
§ Pituitary adenoma - very small location, and the tumor is very small, but it has significant outcome:
□ Compresses the gland, and the hormones will not be secreted
§ Growth in the brain - even if small can have fatal outcomes
§ Growth in vessel wall of renal artery - and blocks flow - renal issues
§ In the liver, blocking flow of ____ will lead to digestion of liver
○ Intussusception
§ Blocking intestinal lumen > tumor protruding into the gut will interrupt the peristaltic movement leading to blockage and then ____ of local tissue
○ Production of hormones
§ Pancreatic b-cell tumor - if well differentiated > will retain some of normal function > insulin production
□ Manifest as hyperinsulinemia (low levels of blood ____)
§ Pituitary adenoma can also produce certain hormones
○ Ulcerate surface (because the vasculature is ____ in cancer)
§ More likely to occur in GI tumors, stomach tumors and colon cancer
□ Bleeding can be massive
□ Bleeding can be small, but ____ - so subtle to not be detectable by patient > can lead to ____

A
location
bile
gangrene
glucose
occult
anemia
21
Q

Effects of Tumor on Host - paraneoplastic syndromes

Paraneoplastic syndromes 
 May precede tumor
\_\_\_\_
 Differ based on tumor \_\_\_\_
 Several mechanisms
Most Common 
 \_\_\_\_
 Cushing Syndrome
 \_\_\_\_
 Nonbacterial thrombotic endocarditis
• Paraneoplastic syndrome
	○ Any symptom that is not directly to the \_\_\_\_, or the \_\_\_\_ that may be acquired by cancer (invasion of tumor into surrounding tissue)
	○ May precede tumor ID, can help the clinician diagnose the cancer
	○ Certain cancers produce certain \_\_\_\_ in paraneoplastic syndromes that can help diagnose the cancer
• Hypercalcemia
	○ If breast tumor goes to bone:
		§ Bone resorption
		§ Increase levels of Ca++ in blood
			□ These are due to \_\_\_\_ of cancer into blood, not paraneoplastic!
	○ Paraneoplastic syndrome:
		§ Production of \_\_\_\_ that will lead to increased levels of Ca++
• Cachexia
	○ Wasting
A

identification
origin
cachexia
hypercalcemia

mass effect
function

hormones
invasion
hormones

22
Q

Miscellaneous (non-specific syndrome)

Non-specific syndrome 
 \_\_\_\_
 Dysgeusia 
 \_\_\_\_ 
 cachexia

Cachexia
 Loss of ____ and ____, Weakness, Anorexia,
Anemia
 Wasting ____ than reduced food intake dictates
 Metabolism is ____, not lower
 Due to cytokines like ____ from Macrophages or tumor cells
 Only treatment is to remove ____

• Dysgeusia - fowl smelling breath
• Cachexia - very thin, very fast weight loss
	○ Non-specific
	○ Not due to \_\_\_\_, or because the tumor is using up the calories
	○ It's because of the \_\_\_\_ released by the tumor cells or the macrophages
		§ TNFa
	○ Patient may not be eating - starvation; however, metabolic rate increases (it would usually decrease)
A

fever
anorexia

fat
lean mass
faster
higher
TNFa
tumor

tumor size
cytokines

23
Q

Paraneoplastic syndromes

Clinically important because
 10-15% of cases
 Often \_\_\_\_ manifestation
 May cause significant morbidity/mortality
 May \_\_\_\_ treatment

Hypercalcemia
 ____
 Most common cause is production of ____ by tumor

• Hypercalcemia
	○ Multifactorial due to production of hormones
	○ PTHrP leads to release of \_\_\_\_
A
early
confound
multifactorial
parathyroid hormone-related protein (PTHrP)
Ca++
24
Q

Paraneoplastic lesions

Cushing syndrome
 ____ disorder
 One cause may be ____
 Increase ____- like peptides by tumor

 Constellation of effects due to ____
 Neurologic, cardiovascular ,immunosuppression, metabolic changes (obesity/____), musculoskeletal changes, etc

• Cushing syndrome
	○ Many reasons for the disorder, cancer is one of them
		§ By itself, Cushing syndrome does not mean the patient has a \_\_\_\_
	○ Hypercortisolism
		§ Immunosuppression exacerbates the conditions in cancer patients
A
endocrine
tumor
ACTH or ACTH
hypercortisolism
moonface
tumor
25
Paraneoplastic lesions Hypercoagulability  ____  ____  More will be discussed in the context of specific tumors • Hypercoagulability leads to thrombosis in the absence of other risk factors (immobility, etc.), ultimately leading to nonbacterial endocarditis
thrombosis | nonbacterial endocarditis
26
Mechanisms of paraneoplastic syndromes ```  Produce ____  Produce immunologic response --- ____ action  Produce ____ molecules  ____ and Infection ```
hormones antibody bioactive ulceration
27
Grading and Staging of cancer  Grading --- Quantify clinical aggressiveness based on ____ presentation, number of mitoses. --- Well differentiated to anaplastic  ____ grades (I, II, III, IV)  ____  Criteria vary for each form of neoplasia ```  Staging  T (1-4)- ____  N(0-3) – ____ involvement  M (0-1) – ____  More clinically ____ for prognosis ``` • Grading ○ Based on microscopy ○ Not as clear cut, some personal intuition is a factor in deciding the grade § Not a very quantitative way, more descriptive • Staging (TNM) ○ More observable gross findings ○ Based on quantitative criteria: § T - tumor size § N - regional lymph node involvement □ ____ - no lymph node involvement □ N1-2 - lesion is on right side of salivary gland and lymph node is on the same side □ N3 - if lesion and lymph node are ____ § M - metastases (the most important to gauge the severity of the tumor) □ M0 - no metastasis □ M1 - ____
cytologic 4 descriptive size regional lymph metastases valuable N0 contralateral metastases
28
Laboratory Diagnosis of Cancer  ____ Methods  Tumor Markers  ____ diagnostics  Molecular profiling of tumors
morphologic | molecular
29
Morphologic Methods  Benign vs Malignant is ____  Middle ground is harder  Other changes may mimic or masks appearance of lesion -- ____, bleeding, ____, radiation damage. Diagnosis depends on  ____ of specimen  Appropriate ____ method  Clinician ____ • Ambiguities - sometimes you see mitoses but the architecture is severely compromised ○ Based on the clinician's skill • Inflammation, bleeding, healing, and radiation damage can mimic/mask the cancerous changes ○ Radiation damage may result in ____ damage and not lead to cancer
easy inflammation healing quality sampling skill/experience temporary
30
Morphologic Methods Sampling ```  Excisional/Incisional biopsy -- Histologic analysis ---- ____, Immunohistochemstiry -- Frozen section diagnosis ---- ____, less preserved architecture  ____ aspirate  ____ smear (papanicolaou)  Flow Cytometry – ____ ```
``` HE faster fine needle cyologic leukemia/lymphoma ```
31
Morphologic Methods Sampling • Frozen section diagnosis ○ Faster, you take in the OR, freeze immediately and look under the scope ○ ____, but important initial diagnosis § Useful in ____, to see if you removed the tumor; check the tissue next to the tumor region ○ Still have to follow it up with a regular ____ analysis • ____ tumors - biopsy • Fine needle aspirate ○ Tumors that have lost ____, or cavities where the cells may be shedding into ○ i.e: ____ tumors • Papanicolaou (cyologic smear) ○ Cells on the ____ may be brushed away § Place on slide and stain them § Normal epithelial cells have nice structure, but cancerous cancer (right): different size, hyperchromatism, mitotic cells and some inflammatory cells ○ Pap smear - reduction in the incidence of ____ cancer ○ Two photos illustrate this process • Flow cytometry (most ____ - more quantitative assessment!) ○ Leukemia/lymphoma ○ Utilizes staining of blood cells § For ____ that recognizes markers that tells us which cell is a lymphocyte, NK cell, monocyte, etc. § Based on ____ protein expression
``` preliminary surgery histological solid cells breast epithelium cervical accurate antibodies CD ```
32
``` Tumor markers  Biochemical Assays for biomarkers --- ____ activity --- ____ level --- Other protein in blood  Useful for screening, prognosis, response to therapy, recurrence ``` ```  Prostate specific antigen (PSA)  Example of successful tumor marker for ____  Also elevated with ____  No PSA doesn’t mean no ____.  Specificity and sensitivity are ____  Useful for ____ and therapy ``` • Using antigens are more ____ • Normally protein levels should be below a cutoff value, but if there's an increase that suggest a cancer that is overexpressing that protein ○ Increased levels of PSA in blood may indicate prostate cancer ○ No change in PSA doesn't mean no cancer - the testing may not be sensitive enough ○ Has low specificity and low sensitivity; but good for surveillance and response to therapy § But can follow levels in changes over time in a person who you know has cancer - allows you to get a ____ reading, and after treatment the levels may go down § If increase in levels - shows that there's a recurrence, but there's also carcinoembryonic antigen, where you can follow levels • Not perfect - not specific to cancer ○ If benign prostatic hyperplasia - PSA levels may also increase
``` enzyme hormonal prostatic adenocarcinoma BPH cancer low recurrence ``` quantitative basal
33
``` Molecular Diagnosis  Diagnosis of Malignancy  Prognosis and behavior  Detection of ____ disease  Diagnosis of predisposition to cancer  Therapeutic decision making ``` ``` Arsenal of molecular methods  ____  Fluorescent In situ hybridization  ____ activity  Deep sequencing ``` • PCR ○ Can ____ any gene of interest and determine if there's a deletion/mutation within the gene • Fluorescent in situ hybridization (FISH) ○ Using dyes to stain ____ ○ Can deduce if ____, deletion or presence of ____ § Philadelphia chromosome • Enzyme activity • Deep sequencing (most ____) ○ Sequence the entire ____ of a cancer growth - gives us the most comprehensive picture of all the genetic alterations
``` minimal residual PCR enzyme amplify chromosomes translocation double minutes advanced DNA ```
34
Molecular Diagnosis ``` Diagnosis of Malignancy  ____ tumors  PCR distinguishes --- Polyclonal ____ rearrangements --- ____ rearrangements --- ____ translocation, common  FISH --- ____ sarcoma, rarer ____ ``` Prognosis and behavior  Poor Prognosis/treatment  ____ – breast cancer  ____ - neuroblastoma • Lymphoid tumors ○ Philadelphia chromosome - can look for translocation that causes the bcr/abl fusion - will give you the diagnosis • FISH ○ Ewing's sarcoma - chromosome defect • Her2/neu overexpression ○ If can look via PCR to see if relative expression is higher than normal ○ If overexpressed, it's associated with ____ outcomes, so you can be more aggressive in treatment ○ Same principle for N-myc
``` lymphoid IgG monoclonal BCR:ABL Ewing's translocations ``` Her2/neu N-myc poor
35
``` Molecular Diagnosis Detection of minimal residual disease  After ____  Increased Sensitivity of ____ methods  Detect changes in small number of cells  ____ for CML ``` ``` Diagnosis of predisposition to cancer  ____ – Breast Cancer  Implement Aggressive Screening protocols  ____ Surgery  Genetic counseling  Patient and offspring ``` • After treatment, can use sensitive molecular methods to detect residual disease ○ May not be obvious in form of mass effect/paraneoplastic syndrome • BRCA1 mutation - more prone to develop breast cancer ○ Patient must be ____ to undergo screening at an earlier age using more refined methods ○ And undergo ____ surgery
treatment PCR BCR:ABL BRCA1 prophylactic counseled prophylactic
36
Therapeutic Decision Making  Recognized that some mutations cross diagnostic criteria or even ____ types  Tailored therapeutics -- B-RAF ---- 60 % of ____ ---- % of colon, thyroid, and Hairy cell leukemia, Langerhans cell histiocytosis  Distinct morphologies  Different Tissues  Same oncogene • B-RAF ○ Downstream from Ras pathway (activates two arms): § PI3K § RAF ○ Mutation in B-RAF > can be targeted by a specific ____ § Run molecular diagnostics > can give patient a specific drug targeting the molecule • Maybe should categorize cancers on ____ lesion, not the location ○ B-RAF mutated, Ras mutated, etc
tissue melanomas drug genetic
37
``` Molecular Profiling Expression profiling  Gene chip or micro array  compare thousands of ____ levels  Has shown differences in ____ expression in tumors from the same category ``` • Silica plates where you have your target ____ • Tumor tissue > isolate ____; control tissue > isolate RNA • Convert to ____, and tag with fluorescent molecules and mix ○ Normal tissue: green, tumor: ____ • Lay on silica plate, and the DNA should bind to targets that are genes (each dot) • If there is a gene that is present in mixture against gene that you're look at > bind ○ If expression of gene is same in tumor and normal > ____ ○ If more of gene (oncogene) in the tumor > ____ ○ If less in tumor tissue > ____ • Can use a ____ piece of tumor tissue and look for relative expression of genes of interest ○ 5-10,000 genes at same time • Shows differences in RNA levels of tumors ○ Looking at oncogenes and TSG's
``` mRNA mRNA gene/probe RNA DNA red yellow red green small ```
38
Molecular Profiling - Next generation sequencing ```  a.k.a. Deep Sequencing  Decreased ____ and cost  Revealed --- Childhood tumors -____ changes, --- Adult tumors 100s – ____ ``` ```  Reveal all mutations in a tumor - Driver mutations -- ____ mutations -- Lead to ____ of cancer - ____ mutations  Refocus therapy from tissue of origin to ____ lesion ``` • Deep sequencing (more comprehensive view) ○ Not limited by number of genes you can look at on plates; can look at the entire genome ○ More ____ - sequences the genome repetitively • Childhood tumors require few changes in order for the tumor to arise, adults require more • Driver mutations ○ Recurrent mutations occur across different patients that lead to hallmarks of cancer § ____, p53 • Passenger mutations ○ More random, not that ____
``` time few 1000s recurrent hallmarks passenger molecular ``` accurate Ras critical
39
• Need to target many ____ of cancer in order to be successful • Require an ____ approach ○ Personalized therapy has become the forefront of cancer • Signature mutation - a specific mutation that is caused by a specific ____ agent that helps you link the ____ agent to the cancer
aspects individualized chemical causative